Tumors suppress a mitochondrial chaperone activity in macrophages to facilitate immune evasion 2455
Abstract Description Unlike the dysfunctional mitochondria of tumor-infiltrating T cells, tumor-associated macrophages (TAMs) maintain their functional mitochondria in the nutrient-deprived tumor microenvironment (TME), promoting an immunosuppressive phenotype. However, the mechanisms underlying this remain unclear. Here, we identify that TNF-receptor associated protein-1 (TRAP1), a mitochondrial chaperone, serves as an endogenous metabolic checkpoint that regulates mitochondrial respiration and drives immunosuppressive function in TAMs. In the TME, TRAP1 expression in TAMs is suppressed via the TIM4-AMPK pathway. Using TRAP1-deficient mice, we observed that TRAP1 loss amplifies immunoinhibitory function in macrophages while reducing proinflammatory activity. Mechanistically, TRAP1 absence enhanced activity of mitochondrial electron transport chain complexes and increased the α-ketoglutarate (α-KG) to succinate ratio. The increase in α-KG facilitates JMJD3-mediated histone demethylation, altering genes expression associated with immunosuppressive activation in macrophages and thereby facilitating tumor immune escape. Notably, boosting TRAP1 expression in TAMs disrupts the immunosuppressive TME, bolstering anti-tumor immunity. These findings underscore TRAP1’s pivotal role in TAM metabolic rewiring and immune modulation, highlighting its potential as a therapeutic target in cancer immunotherapy. Funding Sources Supported by American Cancer Society Research Scholar Grant (RSG-22-135-01-IBCD), Melanoma Research Foundation Career Development Award, Andrew McDonough B+ Foundation Grant Award, Cancer Research Institute CLIP Investigator Award, Case Comprehensive Cancer Center American Cancer Society Pilot Grants (IRG-91-022-19, IRG-16-186-21). Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)
Authors
- Zihai Li (ORCID: https://orcid.org/0000-0003-4603-927X)
- Lydia Raines (ORCID: https://orcid.org/0000-0001-5675-4854)
- Wei Cao (ORCID: https://orcid.org/0000-0002-8952-9159)
- Alex Y. Huang (ORCID: https://orcid.org/0000-0002-5701-4521)
- Jaeoh Park (ORCID: https://orcid.org/0000-0003-2699-371X)
- Chan‐Wang Jerry Lio (ORCID: https://orcid.org/0000-0003-3876-6741)
- Ping‐Chih Ho (ORCID: https://orcid.org/0000-0003-3078-3774)
- Stanley Ching‐Cheng Huang (ORCID: https://orcid.org/0000-0002-6557-3737)
- Haoxin Zhao
- Yuli Ouyang
- Michael Hsu (ORCID: https://orcid.org/0000-0003-3852-1461)
- Heng-Yi Chen (ORCID: https://orcid.org/0000-0001-9283-6144)
- Yuzhu Wang (ORCID: https://orcid.org/0000-0002-0230-5452)
Institutions
- The Ohio State University (US)
- Case Western Reserve University (US)
- University of Lausanne (CH)
Publication Details
- Journal
- The Journal of Immunology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1093/jimmun/vkaf283.371
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health and Medical Research Fund